- Asahi Kasei Pharma Denmark A/S meddeler det endelige resultat det frivillige offentlige købstilbud
- Asahi Kasei Pharma Denmark A/S Announces the Final Result of the Voluntary Public Tender Offer
- BioSig to Commence Patient Cases at Mayo Clinic
- ViaDerma, Inc. Provides a Corporate Update
- Veloxis Pharmaceuticals: Reporting of Managers' and Closely Associated Persons' Transactions in Veloxis-Shares and Financial Instruments Linked Hereto
- Veloxis Pharmaceuticals: Offentliggørelse af ledende medarbejderes og personer, der er nært knyttet til ledende medarbejderes transaktioner med Veloxis-aktier og finansielle instrumenter forbundet hermed
- Gevo secures biogas supply and receives commitment letter for financing
- Dermavant Enters into Exclusive License Agreement with JT for Development and Commercialization of Tapinarof in Japan
- Veloxis Pharmaceuticals: Asahi Kasei Pharma Denmark Announces the Preliminary Result and Completion of its Public Tender Offer for the Shares and Warrants in Veloxis Pharmaceuticals
- Veloxis Pharmaceuticals: Asahi Kasei Pharma Denmark offentliggør det foreløbige resultat af samt afslutningen på dets offentlige købstilbud på aktier og warrants i Veloxis Pharmaceuticals
